October 29, 2025 argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients
October 23, 2025 argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025
October 15, 2025 argenx to Highlight Key Data and Breadth of Immunology Innovation at 2025 AANEM Annual Meeting and MGFA Scientific Session
Follow us
Get the latest news and info via our social media channels.